[1]
M. Fedechko, M. Halkevych, and N. Chmyr, “Main provisions of the ESC recommendation swith the problem of cardioncology (2022). Part 3. Treatment of cardiovascular complications of anticancer therapy and long-term follow-up”, The Praсt., no. 1, pp. 11-19, Mar. 2024.